Literature DB >> 33061201

Outcomes following cardiac transplantation in adults.

Sai Bhagra1, Jayan Parameshwar1.   

Abstract

For a carefully selected group of patients with advanced heart failure where prognosis and quality of life remain poor, cardiac transplantation is the treatment of choice. Long-term survival and quality of life are now excellent in most patients post-transplantation, but important short- and long-term complications remain a significant concern. The mainstay of early and longer term post-transplant care is the surveillance for and treatment of these complications. This review article provides an overview of the contemporary outcomes after heart transplant, the more commonly encountered problems and their management in the early and late stages. © Indian Association of Cardiovascular-Thoracic Surgeons 2019.

Entities:  

Keywords:  Cardiac transplant; Heart transplant; Outcomes

Year:  2019        PMID: 33061201      PMCID: PMC7538517          DOI: 10.1007/s12055-019-00796-0

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  63 in total

1.  Temporal Trends of De Novo Malignancy Development After Heart Transplantation.

Authors:  Jong-Chan Youn; Josef Stehlik; Amber R Wilk; Wida Cherikh; In-Cheol Kim; Gyeong-Hun Park; Lars H Lund; Howard J Eisen; Do Young Kim; Sun Ki Lee; Suk-Won Choi; Seongwoo Han; Kyu-Hyung Ryu; Seok-Min Kang; Jon A Kobashigawa
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

2.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.

Authors:  Mandeep R Mehra; Maria G Crespo-Leiro; Anne Dipchand; Stephan M Ensminger; Nicola E Hiemann; Jon A Kobashigawa; Joren Madsen; Jayan Parameshwar; Randall C Starling; Patricia A Uber
Journal:  J Heart Lung Transplant       Date:  2010-07       Impact factor: 10.247

3.  Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients.

Authors:  B Radovancevic; S Poindexter; S Birovljev; V Velebit; H A McAllister; J M Duncan; D Vega; J Lonquist; C M Burnett; O H Frazier
Journal:  Eur J Cardiothorac Surg       Date:  1990       Impact factor: 4.191

4.  Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors.

Authors:  Alina Nicoara; David Ruffin; Mary Cooter; Chetan B Patel; Annemarie Thompson; Jacob N Schroder; Mani A Daneshmand; Adrian F Hernandez; Joseph G Rogers; Mihai V Podgoreanu; Madhav Swaminathan; Adam Kretzer; Mark Stafford-Smith; Carmelo A Milano; Raquel R Bartz
Journal:  Am J Transplant       Date:  2017-12-14       Impact factor: 8.086

5.  RADIAL: a novel primary graft failure risk score in heart transplantation.

Authors:  Javier Segovia; M Dolores G Cosío; Juan M Barceló; Manuel Gómez Bueno; Pablo García Pavía; Raúl Burgos; Santiago Serrano-Fiz; Carlos García-Montero; Evaristo Castedo; Juan Ugarte; Luis Alonso-Pulpón
Journal:  J Heart Lung Transplant       Date:  2011-04-05       Impact factor: 10.247

6.  The management of antibodies in heart transplantation: An ISHLT consensus document.

Authors:  Jon Kobashigawa; Monica Colvin; Luciano Potena; Duska Dragun; Maria G Crespo-Leiro; Juan F Delgado; Michael Olymbios; Jayan Parameshwar; Jignesh Patel; Elaine Reed; Nancy Reinsmoen; E Rene Rodriguez; Heather Ross; Randall C Starling; Dolly Tyan; Simon Urschel; Andreas Zuckermann
Journal:  J Heart Lung Transplant       Date:  2018-01-31       Impact factor: 10.247

7.  The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.

Authors:  Kevin J Clerkin; Susan W Restaino; Emmanuel Zorn; Elena R Vasilescu; Charles C Marboe; Donna M Mancini
Journal:  J Heart Lung Transplant       Date:  2016-05-06       Impact factor: 10.247

8.  Patterns and predictors of quality of life at 5 to 10 years after heart transplantation.

Authors:  Kathleen L Grady; David C Naftel; Jon Kobashigawa; Julie Chait; James B Young; Dave Pelegrin; Jennifer Czerr; Alain Heroux; Robert Higgins; Bruce Rybarczyk; Mary McLeod; Connie White-Williams; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2007-03-26       Impact factor: 10.247

9.  Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.

Authors:  Jon A Kobashigawa; Daniel F Pauly; Randall C Starling; Howard Eisen; Heather Ross; Shoei-Shen Wang; Bernard Cantin; James A Hill; Patricia Lopez; Gaohong Dong; Stephen J Nicholls
Journal:  JACC Heart Fail       Date:  2013-09-11       Impact factor: 12.035

10.  Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.

Authors:  A K Andreassen; B Andersson; F Gustafsson; H Eiskjaer; G Rådegran; E Gude; K Jansson; D Solbu; K Karason; S Arora; G Dellgren; L Gullestad
Journal:  Am J Transplant       Date:  2016-01-28       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.